A study investigating the safety, absorption, and elimination of RO7795068, a new compound that may potentially be used in the treatment of obesity
Obesity is a long-term condition that can raise the risk of serious health problems such as type 2 diabetes and heart disease. Researchers are testing a new experimental medicine named RO7795068 to see if it could help treat obesity in the future. This is an early Phase 1 study. The main aim is to check the safety of the medicine in humans. Doctors want to understand how the body absorbs, breaks down, and gets rid of the drug. They will also carefully watch for any side effects. The trial is open to adults aged 18 and over. While taking part in an early study like this may not directly improve a person's health, it provides vital information needed before the medicine can be tested in larger groups of people.
At a glance
What is this study about?
Obesity affects millions of people across the UK. Carrying excess weight is not simply about appearance; it can put extra strain on joints, the heart, and other organs. While lifestyle changes such as diet and exercise are important, many people also need medical support to help manage their weight safely. Scientists are constantly working to develop new and better medicines to support weight management.
This trial is looking at a brand-new experimental compound called RO7795068. Because this is a 'Phase 1' study, it is one of the very first times this medicine is being tested in humans. At this stage, doctors are not mainly measuring how much weight people lose. Instead, they are checking how safe the medicine is and how the human body handles it.
During the trial, researchers will track how the drug enters the bloodstream, how it travels around the body, and how quickly it is cleared away. This kind of research is essential. It helps doctors work out what dose might be safe and effective before testing the medicine in larger groups of patients in the future.
Key takeaways
- The trial tests a new experimental drug, RO7795068, for potential future use in treating obesity.
- This is an early Phase 1 study focused mainly on safety and how the drug moves through the body.
- It is open to adults aged 18 and older who meet specific health checks.
- Participants will have regular health tests, including blood checks and heart traces.
- Joining is completely voluntary, and you can leave the study at any time.
Who may be eligible?
This trial is open to adults aged 18 and over. Both men and women can take part. Because it is an early-phase trial, the study team will be looking for participants who meet clear health standards to ensure it is as safe as possible.
Before anyone can join, the research team will carry out a thorough health check. This usually includes a physical exam, blood tests, and heart checks. People with certain serious medical conditions or those taking specific medicines may not be able to join, as these could affect the study results or increase the risk of side effects.
The study team will discuss your full medical history with you to decide if taking part is suitable and safe for your personal circumstances.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged 18 or over.
- I am interested in taking part in an early-stage medical research study.
- I am able to attend clinic appointments and possibly stay overnight if required.
- I am willing to undergo blood tests, heart checks, and physical exams.
- I am happy to discuss my current medications and medical history with the research team.
What does participation involve?
If you take part, you will be invited to a specialist clinic. The study typically starts with a screening visit where doctors check your overall health. You will then receive the study medicine, RO7795068, which may be given as a tablet or an injection. You will be closely monitored by doctors and nurses, which might include staying overnight at the clinic for part of the study. Staff will take regular blood and urine samples, check your blood pressure, and run heart traces (ECGs) to see how your body responds. After completing the treatment, you will have follow-up visits or phone calls to check on your recovery. The total duration can vary from a few weeks to several months depending on the study group.
Potential risks and benefits
Locations (1)
- —UnverifiedNetherlands
Common questions
What is the main goal of this trial?
The goal is to test if RO7795068 is safe for humans and to see how the body absorbs, breaks down, and clears the medicine.
Will taking part help me lose weight?
Probably not. This is an early Phase 1 trial designed to check safety and drug levels, not to provide an effective weight-loss treatment.
Do I have to pay to take part?
No, clinical trials do not cost you anything to join. Many Phase 1 trials also cover travel expenses or provide compensation for your time.
Will I need to stay in a clinic?
Phase 1 studies often involve a short stay at a specialist clinic so doctors can monitor you closely and take regular blood samples.
Can I leave the study early if I want to?
Yes. You have the right to withdraw from the trial at any point, and doing so will never affect your normal medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.